Corbus Pharmaceuticals Holdings Cash Flow Statement (2013-2025) | CRBP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-15.41M	-16.70M	-13.88M	-10.00M	-8.52M	-12.34M	-8.18M	-10.80M	-17.30M	-9.19M	-10.47M	-11.03M	0.19M	0.95M	1.52M	1.78M	-19.77M	-19.15M	1.12M
Depreciation and Depletion (Quarter)	0.27M	0.26M	0.26M	0.21M	0.20M	0.19M	0.19M	0.18M	0.18M	0.20M	0.20M	0.10M	0.20M	0.20M	0.20M	0.10M	0.10M	0.10M	0.10M
Share-based Compensation (Quarter)	2.58M	2.51M	2.60M	1.79M	1.59M	1.51M	1.35M	1.27M	1.03M	0.82M	0.82M	0.80M	982.00	0.00M	0.00M	1.63M	1.71M	0.00M	0.00M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)		4.84M	6.07M	-0.09M	12.76M	0.43M	0.44M	0.16M	0.09M	0.03M	0.03M	0.01M	0.20M	0.74M	0.05M			0.71M	1.44M	1.39M
Asset Writedowns and Impairment (Quarter)			0.61M
Non-cash Items (Quarter)	36.31M	37.29M	38.81M	3.53M	10.37M	10.82M	10.98M	0.36M	21.94M	20.77M	20.82M	20.22M	12.30M	12.17M	0.39M	0.88M	0.45M	0.50M	0.00M	0.37M
Cash from Operations (Quarter)	-21.81M	-17.53M	0.86M	-9.70M	-10.62M	-12.23M	-7.25M	-7.45M	-15.11M	-7.80M	-7.18M	-6.01M	-7.97M	-8.94M	-13.94M	-10.94M	-16.42M	-16.60M	-15.55M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.17M	0.17M	0.02M	0.34M	0.18M	-0.84M	1.20M	-0.66M	0.20M	0.08M	0.15M	0.08M	0.19M	0.13M	2.18M	0.83M	0.20M	-0.20M	0.67M
Amortization of Deferred Charges (Quarter)	0.15M	0.16M	0.16M	0.17M	0.17M
Depreciation & Amortization (CF) (Quarter)	0.27M	0.26M	0.26M	0.21M	0.20M	0.19M	0.19M	0.18M	0.18M	0.16M	0.15M	0.15M	0.15M	0.15M	0.15M	0.13M	0.08M	0.05M	0.05M
Change in Working Capital
Change in Receivables (Quarter)
Change in Account Payables (Quarter)	-3.69M	-1.74M	0.24M	-0.76M	0.57M	-0.99M	-0.81M	0.98M	-0.85M	0.18M	3.19M	-1.50M	-1.13M	-0.90M	1.95M	1.68M	-0.68M	0.17M	-1.28M
Change in Accured Expenses (Quarter)	-4.26M	-2.65M	-1.47M	-3.52M	-4.60M	-0.78M	0.12M	1.17M	0.47M	-0.05M	1.13M	3.48M	-1.63M	1.09M	-3.33M	-1.74M	0.48M	1.75M	4.92M
Other Working Capital Changes (Quarter)	-0.05M	-1.03M	0.34M	-0.60M	-0.20M	-0.35M	-0.29M	-0.29M	0.56M	-1.19M	2.00M	0.09M	-1.23M	0.53M	-0.36M	-0.37M	0.66M	1.66M	-3.51M
Investing Activities
Capital Expenditures (Quarter)				0.05M	0.01M
Sales of Property, Plant and Equipment (Quarter)	0.00M	0.00M	0.00M	0.02M
Change in Acquisitions & Divestments (Quarter)				6.86M	49.45M	41.19M	16.40M	9.38M	18.86M	19.43M	17.52M	13.72M	7.66M	8.39M	23.47M	19.97M	55.73M	35.37M	37.48M
Cash from Investing Activities (Quarter)	-57.42M	-13.10M	0.28M	-3.18M	42.96M	-18.70M	-5.97M	11.78M	5.55M	8.81M	10.90M	10.39M	-98.24M	-16.44M	-15.37M	8.73M	18.12M	17.74M	19.64M
Financing Activities
Cash from Financing Activities (Quarter)	60.41M	-0.26M	-0.10M	0.77M	-0.33M	-0.33M	-0.11M	0.23M	-0.11M	0.02M	-0.82M	-1.91M	106.58M	34.97M	25.04M	-0.01M			2.85M
Additional items
Change in Cash (Quarter)	-18.82M	-30.88M	1.04M	-12.11M	32.02M	-31.26M	-13.33M	4.56M	-9.68M	1.02M	2.90M	2.48M	0.38M	9.58M	-4.26M	-2.23M	1.70M	1.14M	6.94M
Free Cash Flow (Quarter)	-21.81M	-17.53M	0.86M	-9.76M	-10.63M	-12.23M	-7.25M	-7.45M	-15.11M	-7.80M	-7.18M	-6.01M	-7.97M	-8.94M	-13.94M	-10.94M	-16.42M	-16.60M	-15.55M
Net Cash Flow (Quarter)	-18.82M	-30.88M	1.04M	-12.11M	32.02M	-31.26M	-13.33M	4.56M	-9.68M	1.02M	2.90M	2.48M	0.38M	9.58M	-4.26M	-2.23M	1.70M	1.14M	6.94M

Research Tools

Corbus Pharmaceuticals Holdings Cash Flow Statement (2013-2025) | CRBP

Create an account

Sign In

Reset Password